Insight to SBRT
Format
Online
Course
Price
Free
About The Course
Stereotactic body radiation therapy (SBRT) has evolved as a viable alternative to surgery for medically inoperable patients, achieving excellent local control (LC) with relatively minimal toxicity in standard-risk patients. Nevertheless, the maturation of SBRT has fostered debate regarding its use, technique, dose, and fractionation, particularly in the context of patient- and disease-specific characteristics such as tumour size and location.
However, data directly comparing the outcomes of SBRT with those of conventionally fractionated radiotherapy (CONV) is lacking. Definitive radiation therapy (RT) with curative intent has therefore been used as the standard non-invasive definitive treatment alternative to surgical resection. Recent advances in imaging and radiation delivery techniques have allowed for the development of stereotactic body radiation therapy (SBRT).
However, data directly comparing the outcomes of SBRT with those of conventionally fractionated radiotherapy (CONV) is lacking. Definitive radiation therapy (RT) with curative intent has therefore been used as the standard non-invasive definitive treatment alternative to surgical resection. Recent advances in imaging and radiation delivery techniques have allowed for the development of stereotactic body radiation therapy (SBRT).